Add 'Testicular function and fertility in men with homozygous alpha-1 antitrypsin deficiency'

Testicular-function-and-fertility-in-men-with-homozygous-alpha-1-antitrypsin-deficiency.md

@@ -0,0 +1,8 @@
+<br>
+<br>He was given calcium and vitamin D supplements alongside a trial of parenteral [buy testosterone online](https://gliderarch5.bravejournal.net/what-is-the-legality-of-steroids-in-united-states), consisting of Nebido 1 g every 12 weeks, prompted by patient’s desire to address his erectile dysfunction symptoms. His current medication included only Tiotropium inhaler which he used occasionally during exacerbation of symptoms, and he has never had any exposure to oral or inhaled steroid treatment previously. A 61-year-old Caucasian presented to his general practitioner with symptoms of fatigue and erectile dysfunction. We present the case of a patient identified with AATD following an unusual presentation with erectile dysfunction and high [testosterone buy online](https://md.un-hack-bar.de/s/hZubfmid42) level but also elevated sex-hormone binding globulin (SHBG) leading to low free androgen index hence hypogonadal symptoms. This suggests a potential underdiagnosed burden of osteoporotic bone disease in patients with AATD which is not being treated. Another study found osteoporosis in 42.1% of 19 patients with AATD with a PiZZ genotype, the majority of which were newly diagnosed in previously unsuspected patients (seven out of eight patients) who did not receive maintenance oral steroids. Mutations in these areas can lead to non-functional proteins that can polymerise and accumulate in the liver (infantile hepatic cirrhosis).
+Learn more about clinical trials from this National Institutes of Health webpage. Contact a GARD Information Specialist for more information on organizations that may be dedicated to this disease. They may offer online and in-person resources to help people live well with their disease. Patient organizations can help patients and families connect. You can also contact a GARD Information Specialist for help finding experts, centers of excellence, or clinics that focus on your disease. Rare disease experts may work at large research or teaching hospitals, sometimes called centers of excellence. A coordinated team approach ensures that all symptoms are addressed and that care is well-managed.
+Limited evidence suggests that when smoking history is controlled, this group is not at risk for COPD when compared with the general population9. For that reason, it is difficult to get accurate results regarding clinical phenotype. Although the S allele is more common than the Z allele, interestingly, PiSS is not as commonly found as other genotypes6,20,21. The association between PiSZ heterozygosity and risk of developing other complications of AATD such as panniculitis and granulomatosis with polyangiitis is controversial but smaller than PiZZ homozygosity7. It is possible that computed tomography (CT) densitometry or DLCO would be more informative regarding survival given that upper zone density decline is relevant to mortality11 and is common in PiSZ patients. Consequently, the S allele is only a minor risk factor or co-factor for cirrhosis in specific subpopulations such as chronic alcohol abusers.
+BEAM-302 is a lipid nanoparticle-delivered base editing therapy designed to correct the PiZ mutation in the SERPINA1 gene, enabling production of normal AAT in liver cells. Clinical outcomes such as lung function or liver histology have not yet been reported. Your tax-deductible donation funds lung disease and lung cancer research, new treatments, lung health education, and more. If your healthcare provider suspects AAT deficiency is affecting the liver, the provider may order blood testing of liver function and in some cases an ultrasound of the liver. Lung and liver transplantation are reserved for severe and terminal cases of AATD.96 After liver transplantation, AATD is corrected because the phenotype-normal donor liver produces and  [kjer-bendixen-4.technetbloggers.de](https://kjer-bendixen-4.technetbloggers.de/order-testosterone-cypionate-us-domestic-shipping-pay-with-bitcoin) secretes AAT. When AAT replacement is indicated, it should follow the criteria described in this document.1,9,108,114 Experience with lung volume reduction surgery in patients with AATD is limited. It is interesting to use questionnaires to assess quality of life, assess COPD, and monitor exacerbations.9,105 Despite the cost, AAT replacement is a specific treatment that will slow the destruction of the lung parenchyma, consequently increasing survival,108 and should therefore be offered to all those who need it.
+Because only about 5% of rare diseases have FDA-approved treatments, finding the right healthcare team to manage your symptoms and overall health is essential. Since a probable link between timing of withdrawal of replacement therapy in AATD patients and anastomotic complications might be present, new strategies should be considered when referring these patients for lung transplant. Although recommendations for general treatment in AATD are based on usual COPD management, the majority of COPD pharmacotherapy clinical trials exclude these patients58,61–65. This uncertainty, and the presence of asthma symptoms, with fixed or reversible obstruction in lung function in significant numbers of AATD patients, is a factor behind the recommendation to test for AATD in a wide range of respiratory patients39. Other rarer forms of AATD might be present, so unexplained bronchiectasis, granulomatosis with polyangiitis, necrotizing panniculitis, and liver disease of unknown etiology should also prompt further AATD testing14,25,27,28.
+In patients with lung or liver disease, below-normal serum AAT values should represent a warning sign for further investigation. Unfortunately, it is possible that only 10% of cases of AATD are diagnosed, a high rate of underdiagnosis that precludes genetic counseling and makes appropriate treatment difficult.8 The determination of serum concentrations of AAT is recommended in all patients with COPD, liver disease, necrotizing panniculitis, granulomatosis with polyangiitis, or bronchiectasis without a defined cause.2,9 The World Health Organization (WHO) suggests that patients diagnosed with late-onset asthma be evaluated for AATD.10 A unifying diagnosis of alpha-1 antitrypsin deficiency (AATD) brought together his coexistent mild chronic obstructive pulmonary disease as well as a new finding of previously unrecognised liver disease. To avoid or reduce the destruction of lung parenchyma by AATD is the primary goal of AAT replacement therapy,99 given that intravenous augmentation by infusion of combined human alpha-1 trypsin inhibitor is the most direct, efficient, and unique means of increasing AAT concentrations in the blood and lung interstitium and of preventing the progression of emphysema to a more severe form.100 These polymers can lead to inflammation, with consequent liver fibrosis, cirrhosis, and increased risk of hepatocellular carcinoma, especially in individuals with hepatitis B.55 Because liver disease is highly variable and not all patients with the ZZ genotype develop the disease despite the presence of polymers in the liver, there must be other causal factors that are not yet fully understood.
+<br>